Skip to main content
Clinical Trials/ITMCTR2000003399
ITMCTR2000003399
Not yet recruiting
Phase 1

Establishment of a scoring system for predicting postangioplasty restenosis of arteriovenous fistulas and observation on the clinical effect of external treatment with Sanhuang Ointment

Traditional Chinese Medicine Hospital of Hangzhou0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Traditional Chinese Medicine Hospital of Hangzhou
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Traditional Chinese Medicine Hospital of Hangzhou

Eligibility Criteria

Inclusion Criteria

  • 1\. Maintenance hemodialysis patients with AVF established for more than 3 months;
  • 2\. Patients aged \>\= 18 years;
  • 3\. Patients with type I stenosis located near the anastomotic site;
  • 4\. Patients who received PTA for the first time;
  • 5\. Patients who cooperate with treatment and follow\-up and sign informed consent.

Exclusion Criteria

  • 1\. Patients with infection, malignant tumor, acute cardiovascular and cerebrovascular events, severe gastrointestinal bleeding or liver disease need to be hospitalized;
  • 2\. In the patients with advanced AVF, the internal fistula can not be punctured normally for more than 6 months;
  • 3\. Patients with simultaneous central venous catheter;
  • 4\. Patients who need to use cutting balloon, medicine coated balloon, stent placement or surgery for PTA failure;
  • 5\. Patients with stenosis located at the puncture site of internal fistula and unable to change the puncture site;
  • 6\. The subjects were allergic or intolerant to Sanhuang Ointment or fir;
  • 7\. The subjects were undergoing hemodialysis and peritoneal dialysis;
  • 8\. Subjects are participating in other clinical trials related to vascular access.

Outcomes

Primary Outcomes

Not specified

Similar Trials